SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma

British Journal of Cancer

Volumn 111, Issue 11, 2014, Pages 2114-2121

  Dhanda, J ^a   Triantafyllou, A ^a,b   Liloglou, T ^a   Kalirai, H ^a   Lloyd, B ^a   Hanlon, R ^b   Shaw, R J ^a,b   Sibson, D R ^a   Risk, J M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

extracapsular spread; magnetic resonance imaging; metastasis; oral squamous cell carcinoma; prognosis; Serpine; smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CISPLATIN; MESSENGER RNA; SERPINE1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ACTA2 PROTEIN, HUMAN; ACTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXTRACAPSULAR SPREAD; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; TISSUE SECTION; TUMOR INVASION; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS;

EID: 84927176652     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.500     Document Type: Article

References (69)

1. Alvi A, Johnson JT (1996) Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 114(1): 65-70.
2. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371(9625): 1695-1709.
3. Baker EA, Leaper DJ, Hayter JP, Dickenson AJ (2007) Plasminogen activator system in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 45(8): 623-627.
4. Barry CP, Katre C, Papa E, Brown JS, Shaw RJ, Bekiroglu F, Lowe D, Rogers SN (2013) De-escalation of surgery for early oral cancer-is it oncologically safe? Br J Oral Maxillofac Surg 51(1): 30-36.
5. Bryne M, Koppang HS, Lilleng R, Kjaerheim A (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166(4): 375-381.
6. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56(11): 2488-2492.
7. Chen C, Mendez E, Houck J, Fan W, Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG, Schwartz SM, Zhao LP (2008) Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17(8): 2152-2162.
8. Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V, Emmert-Buck MR (2002) Post-analysis follow-up and validation of microarray experiments. Nat Genet 32(Suppl): 509-514.
9. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, Shockley WW, Weissler MC, Dressler LG, Shores CG, Yarbrough WG, Perou CM (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5(5): 489-500.
10. Colella S, Richards KL, Bachinski LL, Baggerly KA, Tsavachidis S, Lang JC, Schuller DE, Krahe R (2008) Molecular signatures of metastasis in head and neck cancer. Head Neck 30(10): 1273-1283.
11. Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, Ploug M, Romer J (2005) Plasminogen activation and cancer. Thromb Haemost 93(4): 676-681.
12. Dobrossy L (2005) Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24(1): 9-17.
13. Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10(1): 39-49.
14. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P (1995) Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 72(5): 1180-1188.
15. Franceschi D, Gupta R, Spiro RH, Shah JP (1993) Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 166(4): 360-365.
16. Gandolfo GM, Conti L, Vercillo M (1996) Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma. Anticancer Res 16(4B): 2155-2159.
17. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97(6): 1464-1470.
18. Gulmann C, Butler D, Kay E, Grace A, Leader M (2003) Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42(1): 70-76.
19. Hayashido Y, Hamana T, Yoshioka Y, Kitano H, Koizumi K, Okamoto T (2005) Plasminogen activator/plasmin system suppresses cell-cell adhesion of oral squamous cell carcinoma cells via proteolysis of E-cadherin. Int J Oncol 27(3): 693-698.
20. Hoffman EP, Awad T, Palma J, Webster T, Hubbell E, Warrington JA, Spira A, Wright G, Buckley J, Triche T, Davis R, Tibshirani R (2004) Expression profiling-best practices for data generation and interpretation in clinical trials. Nat Rev Genet 5(3): 229-237.
21. Hoos A, Cordon-Cardo C (2001) Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 81(10): 1331-1338.
22. Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, Lin CY, Lee LY, Wang TH, Yen TC, Shen CR, Chen IH, Chiu CC, Cheng AJ (2009) Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett 284(2): 131-140.
23. Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Okamune A, Sugiura S, Noguchi N, Yamamoto E (2011) Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. J Oral Pathol Med 40(9): 693-698.
24. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Nishimoto I, Kowalski LP, Coletta RD (2007) Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 51(6): 849-853.
25. Klein RM, Bernstein D, Higgins SP, Higgins CE, Higgins PJ (2012) SERPINE1 expression discriminates site-specific metastasis in human melanoma. Exp Dermatol 21(7): 551-554.
26. Kondoh N, Ishikawa T, Ohkura S, Arai M, Hada A, Yamazaki Y, Kitagawa Y, Shindoh M, Takahashi M, Ando T, Sato Y, Izumo T, Hitomi K, Yamamoto M (2008) Gene expression signatures that classify the mode of invasion of primary oral squamous cell carcinomas. Mol Carcinog 47(10): 744-756.
27. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1): 9-22.
28. Liao LJ, Lo WC, Hsu WL, Wang CT, Lai MS (2012) Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer 12: 236.
29. Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC (2008) Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol 214(4): 489-497.
30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408.
31. Lopes V, Murray P, Williams H, Woodman C, Watkinson J, Robinson M (2011) Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus. Oral Oncol 47(8): 698-701.
32. Lwin CT, Hanlon R, Lowe D, Brown JS, Woolgar JA, Triantafyllou A, Rogers SN, Bekiroglu F, Lewis-Jones H, Wieshmann H, Shaw RJ (2012) Accuracy of MRI in prediction of tumour thickness and nodal stage in oral squamous cell carcinoma. Oral Oncology 48(2): 149-154.
33. Marsh D, Suchak K, Moutasim KA, Vallath S, Hopper C, Jerjes W, Upile T, Kalavrezos N, Violette SM, Weinreb PH, Chester KA, Chana JS, Marshall JF, Hart IR, Hackshaw AK, Piper K, Thomas GJ (2011) Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 223(4): 470-481.
34. Mendez E, Fan W, Choi P, Agoff SN, Whipple M, Farwell DG, Futran ND, Weymuller Jr. EA, Zhao LP, Chen C (2007) Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma. Head Neck 29(9): 803-814.
35. Mendez E, Houck JR, Doody DR, Fan W, Lohavanichbutr P, Rue TC, Yueh B, Futran ND, Upton MP, Farwell DG, Heagerty PJ, Zhao LP, Schwartz SM, Chen C (2009) A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res 15(4): 1353-1361.
36. Mroz EA, Rocco JW (2012) Gene expression analysis as a tool in early-stage oral cancer management. J Clin Oncol 30(33): 4053-4055.
37. Myers JN, Greenberg JS, Mo V, Roberts D (2001) Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 92(12): 3030-3036.
38. O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B, Cheng Y, Putt M, Feldman M, Ziober B, Muschel RJ (2005) Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24(7): 1244-1251.
39. Parsons M, Grabsch H (2009) How to make tissue microarrays. Diagn Histopathol 15(3): 142-150.
40. Piffko J, Bankfalvi A, Tory K, Fuzesi L, Bryne M, Ofner D, Kusch F, Joos U, Schmid KW (1998) Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas. Head Neck 20(1): 8-15.
41. Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM (2006) 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 95(10): 1432-1438.
42. Rajeevan MS, Vernon SD, Taysavang N, Unger ER (2001) Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3(1): 26-31.
43. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33(1): 49-54.
44. Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, Abecassis J, Wasylyk B (2008) Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 27(51): 6607-6622.
45. Roepman P, de Jager A, Groot Koerkamp MJ, Kummer JA, Slootweg PJ, Holstege FC (2006) Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Res 66(23): 11110-11114.
46. Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, Tilanus MG, Koole R, Hordijk GJ, van der Vliet PC, Reinders MJ, Slootweg PJ, Holstege FC (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37(2): 182-186.
47. Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, Sutton D, Errington D, Vaughan D (2009) Survival following primary surgery for oral cancer. Oral Oncol 45(3): 201-211.
48. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, Harvey-Woodworth C, Sisson D, Shaw RJ (2011) Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 17(19): 6262-6271.
49. Schlecht NF, Burk RD, Adrien L, Dunne A, Kawachi N, Sarta C, Chen Q, Brandwein-Gensler M, Prystowsky MB, Childs G, Smith RV, Belbin TJ (2007) Gene expression profiles in HPV-infected head and neck cancer. J Pathol 213(3): 283-293.
50. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(3): 295-302.
51. Severino P, Alvares AM, Michaluart Jr. P, Okamoto OK, Nunes FD, Moreira-Filho CA, Tajara EH (2008) Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes 1: 113.
52. Shaw RJ, Hobkirk AJ, Nikolaidis G, Woolgar JA, Triantafyllou A, Brown JS, Liloglou T, Risk JM (2013) Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2. Ann Surg Oncol 20(8): 2796-2802.
53. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM (2006) Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94(4): 561-568.
54. Shaw RJ, Lowe D,Woolgar JA, Brown JS, Vaughan ED, Evans C, Lewis-Jones H, Hanlon R, Hall GL, Rogers SN (2010) Extracapsular spread in oral squamous cell carcinoma. Head Neck 32(6): 714-722.
55. Shaw RJ, Pace-Balzan A, Butterworth C (2011) Contemporary clinical management of oral squamous cell carcinoma. Periodontol 2000 57(1): 89-101.
56. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH (2006) Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12(3 Pt 1): 701-709.
57. Surowiak P, Murawa D, Materna V, Maciejczyk A, Pudelko M, Ciesla S, Breborowicz J, Murawa P, Zabel M, Dietel M, Lage H (2007) Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor. Anticancer Res 27(4C): 2917-2924.
58. Thode C, Jorgensen TG, Dabelsteen E, Mackenzie I, Dabelsteen S (2011) Significance of myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med 40(3): 201-207.
59. Timar J, Csuka O, Remenar E, Repassy G, Kasler M (2005) Progression of head and neck squamous cell cancer. Cancer Metastasis Rev 24(1): 107-127.
60. Toruner GA, Ulger C, Alkan M, Galante AT, Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN, Dermody JJ (2004) Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 154(1): 27-35.
61. Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M (2007) Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 13(7): 2082-2090.
62. van den Brekel MW, Castelijns JA, Stel HV, Valk J, Croll GA, Golding RP, Luth WJ, Meyer CJ, Snow GB (1990) Detection and characterization of metastatic cervical adenopathy by MR imaging: comparison of different MR techniques. J Comput Assist Tomogr 14(4): 581-589.
63. van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, van Velthuysen ML, van Diest PJ, van Es RJ, Merkx MA, Kummer JA, Leemans CR, Schuuring E, Langendijk JA, Lacko M, De Herdt MJ, Jansen JC, Brakenhoff RH, Slootweg PJ, Takes RP, Holstege FC (2012a) Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol 30(33): 4104-4110.
64. van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, van Velthuysen ML, van Diest PJ, van Es RJ, Merkx MA, Kummer JA, Leemans CR, Schuuring E, Langendijk JA, Lacko M, De Herdt MJ, Jansen JC, Brakenhoff RH, Slootweg PJ, Takes RP, Holstege FC (2012b) Validation of a Gene Expression Signature for Assessment of Lymph Node Metastasis in Oral Squamous Cell Carcinoma. J Clin Oncol 30(33): 4104-4110.
65. Vered M, Dobriyan A, Dayan D, Yahalom R, Talmi YP, Bedrin L, Barshack I, Taicher S (2010) Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer. Cancer Sci 101(1): 274-280.
66. Woolgar JW, Triantafyllou A (2009) Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis: University of Liverpool. Oral Oncol 45(4-5): 361-385.
67. Yasuda T, Sakata Y, Kitamura K, Morita M, Ishida T (1997) Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck. Head Neck 19(7): 611-616.
68. Yu YH, Kuo HK, Chang KW (2008) The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS One 3(9): e3215.
69. Zhou X, Temam S, Oh M, Pungpravat N, Huang BL, Mao L, Wong DT (2006) Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8(11): 925-932.